Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $311.42 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $121.79 | 1 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $120.32 | 4 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $69.31 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.29 | 2 | Novo Nordisk Inc ($121.79) |
| 2023 | $28.06 | 1 | Alnylam Pharmaceuticals Inc. ($28.06) |
| 2022 | $54.76 | 2 | Alnylam Pharmaceuticals Inc. ($54.76) |
| 2019 | $69.31 | 2 | Alexion Pharmaceuticals, Inc. ($69.31) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: Genetic Disease | ||||||
| 04/11/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: Rare Disease | ||||||
| 10/25/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Genetic Disease | ||||||
| 12/16/2022 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Genetic Disease | ||||||
| 07/25/2022 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Genetic Disease | ||||||
| 09/03/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.25 | General |
| 03/08/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $48.06 | General |
About Dr. Marissa Lipton, MD
Dr. Marissa Lipton, MD is a Pediatric Nephrology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1710397245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marissa Lipton, MD has received a total of $311.42 in payments from pharmaceutical and medical device companies, with $159.29 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($311.42).
Practice Information
- Specialty Pediatric Nephrology
- Location New York, NY
- Active Since 05/06/2014
- Last Updated 06/17/2021
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1710397245
Products in Payments
- Rivfloza (Drug) $121.79
- OXLUMO (Drug) $120.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Nephrology Doctors in New York
Howard Trachtman, Md, MD
Pediatric Nephrology — Payments: $201,480
Hilary Hotchkiss, M.d, M.D
Pediatric Nephrology — Payments: $150,543
Dr. David Goldsmith, M.d, M.D
Pediatric Nephrology — Payments: $55,762
Dr. Namrata Jain, Md, MD
Pediatric Nephrology — Payments: $1,126
Dr. Laura Malaga Dieguez, M.d. Ph.d, M.D. PH.D
Pediatric Nephrology — Payments: $578.31
Hilda Fernandez, Md, MD
Pediatric Nephrology — Payments: $387.21